Huperzine A for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials.
<h4>Background</h4>Huperzine A is a Chinese herb extract used for Alzheimer's disease. We conducted this review to evaluate the beneficial and harmful effect of Huperzine A for treatment of Alzheimer's disease.<h4>Methods</h4>We searched for randomized clinical tria...
Guardado en:
Autores principales: | Guoyan Yang, Yuyi Wang, Jinzhou Tian, Jian-Ping Liu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/01426edd48dc4a959458e46f8ddbc23c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer’s Disease
por: María Jesús Friedli, et al.
Publicado: (2021) -
Physical activity can improve cognition in patients with Alzheimer’s disease: a systematic review and meta-analysis of randomized controlled trials
por: Du Z, et al.
Publicado: (2018) -
Administration of dietary antioxidants for patients with inflammatory bowel disease: A systematic review and meta-analysis of randomized controlled clinical trials
por: Hossein Shahinfar, et al.
Publicado: (2021) -
Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer’s disease
por: Meng QQ, et al.
Publicado: (2018) -
Somatostatin analog therapy effectiveness on the progression of polycystic kidney and liver disease: A systematic review and meta-analysis of randomized clinical trials.
por: Tatsuya Suwabe, et al.
Publicado: (2021)